On October 5, the Daily Mail headlined a Cell Metabolism trial as proof that a low-carb diet can “REVERSE liver damage”. The trial followed 42 people for about 4 to 5 months and measured fat in the liver. Read the headline as a sentence. Its subject is “The diet”, and the diet acts alone: it can “REVERSE” damage. The people do not appear: 42 adults who ate food the research team supplied, met a dietitian every week and lost about 10% of their weight. Liver fat fell in every group, 67% on keto and 45% on the other two. The headline keeps the gap and drops the floor: every diet cut liver fat by nearly half once people lost the weight. The page is fairer than its top line. The 24th paragraph says the study “was small” and that it “remains unclear” whether the benefits outlast the diet, and the next paragraphs ask for larger, longer studies. “Damage” appears in the body once, inside a question in the 27th paragraph. The measured result is real and worth reporting. The tell is a verb in capitals that the study’s own outcome cannot carry: set what was measured beside what was promised. The miracle has no price tag. The article names no plan, product or seller and carries no paid-content or affiliate disclosure. What it offers is relief: a feared condition answered by a “trendy” diet, pictured as four glistening sausages, the kind of plate a reader may already enjoy. ScienceDaily’s line, “Keto diet cut liver fat by 67% in a clinical trial”, reports the same study with a number, a measure and no rescue.
